Evelyn Partners Investment Management LLP Astrazeneca PLC Transaction History
Evelyn Partners Investment Management LLP
- $3.52 Trillion
- Q3 2025
A detailed history of Evelyn Partners Investment Management LLP transactions in Astrazeneca PLC stock. As of the latest transaction made, Evelyn Partners Investment Management LLP holds 7,298 shares of AZN stock, worth $650,251. This represents 0.02% of its overall portfolio holdings.
Number of Shares
7,298
Previous 4,198
73.84%
Holding current value
$650,251
Previous $293 Million
90.94%
% of portfolio
0.02%
Previous 0.01%
Shares
3 transactions
Others Institutions Holding AZN
# of Institutions
1,478Shares Held
492MCall Options Held
6.18MPut Options Held
3.01M-
Price T Rowe Associates Inc Baltimore, MD49.1MShares$4.38 Billion0.4% of portfolio
-
Primecap Management CO Pasadena, CA39.9MShares$3.55 Billion2.42% of portfolio
-
Bank Of America Corp Charlotte, NC32.6MShares$2.91 Billion0.18% of portfolio
-
Wellington Management Group LLP Boston, MA32.3MShares$2.88 Billion0.45% of portfolio
-
Capital International Investors Los Angeles, CA25.1MShares$2.23 Billion0.33% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $276B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...